News

Pharmabiz21h
CDSCO issues SEC guidance document elaborating application, recommendation processes
CDSCO issues SEC guidance document elaborating application, recommendation processes: Gireesh Babu, New Delhi Monday, July 21 ...
Pharmabiz21h
FPME’s “Export Pe Charcha” highlights merchant exporters’ role in making drugs globally accessible
FPME’s “Export Pe Charcha” highlights merchant exporters’ role in making drugs globally accessible: Shardul Nautiyal, Mumbai ...
Pharmabiz11h
Clearside Biomedical to explore strategic alternatives to advance its proprietary SCS delivery platform and promising ophthalmology pipeline
Clearside’s innovative SCS Microinjector is being used in commercial ophthalmic products and promising clinical development programs by Aura Biosciences, Bausch + Lomb, BioCryst Pharmaceuticals, ...
Pharmabiz11h
Kenvue collaborates with API to launch India’s first cough clinics to advance symptom science in respiratory primary care
Our Bureau, Mumbai Monday, July 21, 2025, 17:15 Hrs [IST] ...
Pharmabiz13h
Jagat Pharma relaunches Isotine Eye Gummy for kids with an improved formulation and a new flavour
Jagat Pharma relaunches Isotine Eye Gummy for kids with an improved formulation and a new flavour: Our Bureau, Mumbai Monday, July 21, 2025, 16:10 Hrs [IST] Jagat Pharma, a truste ...
Pharmabiz15h
UK MHRA approves ALK’s EURneffy, a needle-free anaphylaxis treatment of adults and children in UK
UK MHRA approves ALK’s EURneffy, a needle-free anaphylaxis treatment of adults and children in UK: Hørsholm, Denmark Monday, July 21, 2025, 14:00 Hrs [IST] ALK, a global specia ...
Pharmabiz12h
Venus Foundation inks 5-year MoU with Haryana govt to transform government schools into future-ready learning hubs
Our Bureau, Bengaluru Monday, July 21, 2025, 16:20 Hrs [IST] ...
Pharmabiz13h
Saluda Medical announces full US launch of EVA sensing technology for use with the Evoke SmartLoop System
Saluda Medical announces full US launch of EVA sensing technology for use with the Evoke SmartLoop System: Minneapolis Monday, July 21, 2025, 16:00 Hrs [IST] Saluda Medical, Inc., ...
Pharmabiz18h
Viatris announces phase 3 study of MR-139 for blepharitis fails to meet its primary endpoint
Viatris announces phase 3 study of MR-139 for blepharitis fails to meet its primary endpoint: Pittsburgh Monday, July 21, 2025, 11:00 Hrs [IST] Viatris Inc., a global healthcare c ...
Pharmabiz12h
Sun Pharma announces positive results from phase 3 clinical studies evaluating tildrakizumab 100 mg in active psoriatic arthritis
Our Bureau, Mumbai Monday, July 21, 2025, 16:30 Hrs [IST] ...
Pharmabiz20h
60 Degrees Pharma & Tulane University ink research agreement to study tafenoquine against Lyme and Bartonella bacteria
Degrees Pharma & Tulane University ink research agreement to study tafenoquine against Lyme and Bartonella bacteria: Washington Monday, July 21, 2025, 09:00 Hrs [IST] 60 Degree ...
Pharmabiz19h
CDSCO declares 185 drug samples as NSQ in June
The Central Drugs Standard Control Organisation (CDSCO) has declared 185 drug samples tested by the Central and State drugs regulatory authorities in the month of June as Not of Standard Quality (NSQ) ...